Structure–Activity Relationship of the Epothilones and the First In Vivo Comparison with Paclitaxel
作者
Dai‐Shi Su,Aaron Balog,Dongfang Meng,Peter Bertinato,Samuel J. Danishefsky,Yu‐Huang Zheng,Ting‐Chao Chou,Lifeng He,Susan Band Horwitz
出处
期刊:日期:1997-10-17卷期号:36 (19): 2093-2096被引量:124
标识
DOI:10.1002/anie.199720931
摘要
Ahead! Epothilone B (1, RMe) displayed better antitumor activity than paclitaxel (Taxol), as shown by in vivo studies with resistant mouse tumor models. The "acyl sector" C1C8 in the epothilones is very sensitive to modification. The other two sectors (see structure on the right) can be varied to a certain extent; however, none of the analogues examined thus far have surpassed the parent compound.